- Home
- ASTI vs PRFX Comparison
ASTI vs PRFX Comparison
Compare ASTI & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- PRFX
- Stock Information
- Founded
- ASTI 2005
- PRFX 2007
- Country
- ASTI United States
- PRFX Israel
- Employees
- ASTI N/A
- PRFX N/A
- Industry
- ASTI Semiconductors
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- PRFX Health Care
- Exchange
- ASTI Nasdaq
- PRFX Nasdaq
- Market Cap
- ASTI 2.9M
- PRFX 2.9M
- IPO Year
- ASTI N/A
- PRFX 2020
- Fundamental
- Price
- ASTI $2.08
- PRFX $1.38
- Analyst Decision
- ASTI
- PRFX Hold
- Analyst Count
- ASTI 0
- PRFX 1
- Target Price
- ASTI N/A
- PRFX N/A
- AVG Volume (30 Days)
- ASTI 6.7M
- PRFX 316.5K
- Earning Date
- ASTI 08-05-2025
- PRFX 08-14-2025
- Dividend Yield
- ASTI N/A
- PRFX N/A
- EPS Growth
- ASTI N/A
- PRFX N/A
- EPS
- ASTI N/A
- PRFX N/A
- Revenue
- ASTI $51,917.00
- PRFX N/A
- Revenue This Year
- ASTI N/A
- PRFX N/A
- Revenue Next Year
- ASTI N/A
- PRFX N/A
- P/E Ratio
- ASTI N/A
- PRFX N/A
- Revenue Growth
- ASTI N/A
- PRFX N/A
- 52 Week Low
- ASTI $1.10
- PRFX $1.25
- 52 Week High
- ASTI $11.10
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- ASTI 51.97
- PRFX 35.23
- Support Level
- ASTI $2.10
- PRFX $1.25
- Resistance Level
- ASTI $2.64
- PRFX $1.48
- Average True Range (ATR)
- ASTI 0.49
- PRFX 0.11
- MACD
- ASTI -0.00
- PRFX 0.00
- Stochastic Oscillator
- ASTI 37.32
- PRFX 29.53
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.